Menu

Merck Buys Sigma-Aldrich for $17B

Two giants merge as the German drug maker acquires the US-based science supply company.

Sep 22, 2014
Kerry Grens

WIKIMEDIA, GERIBETH CIULLOThe German pharmaceutical and chemical company Merck is purchasing Sigma-Aldrich, which supplies a wide swath of lab reagents, for a whopping $17 billion. According to Reuters, the deal contributes to a record-breaking year for transactions in the healthcare industry, “with year-to-date activity in the sector topping $380 billion, well over double the year-ago level, according to Thomson Reuters data.”

Merck has been growing its lab supply side to become one of the biggest companies in the business, having bought EMD Millipore (a.k.a. Merck Millipore), which sells reagents and lab tools, in 2010. “Sigma helps fill in a lot of the missing pieces” for Merck, Ross Muken, a life sciences industry analyst with ISI Group LLC in New York, told The Wall Street Journal. Merck will now sell the range of life science products, from basic science tools and reagents to pharmaceuticals.

According to the Associated Press, Merck CEO Karl-Ludwig Kley said the firm had a “clear commitment” to St. Louis, Missouri, where Sigma-Aldrich is based. According to the news report, “he said it was too early in the integration process to answer a question about possible job losses at any of the company’s facilities.”

April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Marketplace

Sponsored Product Updates

Myth Busting: The Best Way to Use Pure Water in the Lab
Myth Busting: The Best Way to Use Pure Water in the Lab
Download this white paper from ELGA LabWater to learn about the role of pure water in the laboratory and the advantages of in-house water purification!
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu Corporation announces the release of the Nexera Ultra High-Performance Liquid Chromatograph series, incorporating artificial intelligence as Analytical Intelligence, allowing systems to detect and resolve issues automatically. The Nexera series makes lab management simple by integrating IoT and device networking, enabling users to easily review instrument status, optimize resource allocation, and achieve higher throughput.
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
Increasing accuracy and reducing cost barriers, IDT’s innovative system delivers simple and cost-effective amplicon sequencing
Bio-Rad Introduces Isotype-Specific Secondary Antibodies
Bio-Rad Introduces Isotype-Specific Secondary Antibodies
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of its isotype-specific secondary antibodies. This new range of recombinant monoclonal antibodies, directed against the three main mouse isotypes: IgG1, IgG2a, and IgG2b, offer improved signal detection and specificity in imaging, ELISA, flow cytometry, and western blotting.